Where is Sanofi (SNY) Headed According to Wall Street?

Sanofi (NASDAQ:SNY) is one of the best affordable healthcare stocks to buy now. Sanofi (NASDAQ:SNY) announced on December 24 an agreement to acquire Dynavax Technologies Corporation, which is a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and a differentiated shingles vaccine candidate. Dynavax’s adult hepatitis B vaccine HEPLISAV-B is marketed in the United States, and holds a differentiated position due to its its two-dose regimen over one month compared to other hepatitis B vaccines, which are administered in three doses over six months.

In another development, Berenberg Bank analyst Luisa Hector reaffirmed a Buy rating on Sanofi (NASDAQ:SNY) on December 19 and set a price target of €105.00.

The same day, Sanofi (NASDAQ:SNY) announced an agreement with the Donald Trump administration to ensure increased access to affordable medications granted to American patients while simultaneously supporting the country’s role in biopharmaceutical manufacturing and innovation. The agreement entails Sanofi (NASDAQ:SNY) confirming its growth strategy to support its role as a driver of progress and positive impact by taking the lead through “breakthrough science”.

Management reported that the confidential and voluntary agreement between President Trump’s administration and the company satisfies all four requests outlined in the President’s July 31, 2025, letter, and would ensure that certain Sanofi (NASDAQ:SNY) medications can be accessed by state Medicaid programs at the same prices available to other high-income nations. The agreement would thus slash prices by an average of 61% for particular medications targeting cardiovascular and neurological conditions, diabetes, and cancer. Sanofi (NASDAQ:SNY) added that it would also provide consumers access to lower-cost medicines via the TrumpRx.gov and other direct-to-patient platforms, offering nearly 70% of average savings on particular medicines that treat diabetic and cardiovascular conditions.

Sanofi (NASDAQ:SNY) researches, produces, and distributes pharmaceutical products. The company’s operations are divided into the Pharmaceuticals, Consumer Healthcare, and Vaccines segments.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.